Conjugation of chlorins with spermine enhances phototoxicity to cancer cells in vitro
Language English Country Switzerland Media print-electronic
Document type Journal Article
PubMed
28236685
DOI
10.1016/j.jphotobiol.2017.02.012
PII: S1011-1344(16)30945-9
Knihovny.cz E-resources
- Keywords
- Chlorins, Flow cytometry, Photodynamic therapy, Photosensitizers, Phototoxicity, Spermine,
- MeSH
- Apoptosis drug effects radiation effects MeSH
- Chlorophyll analogs & derivatives chemistry MeSH
- Photochemotherapy methods MeSH
- Photosensitizing Agents chemistry MeSH
- HeLa Cells MeSH
- Hydrophobic and Hydrophilic Interactions MeSH
- Humans MeSH
- Cell Line, Tumor drug effects radiation effects MeSH
- Porphyrins chemistry MeSH
- Spermine chemistry MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- chlorin MeSH Browser
- Chlorophyll MeSH
- Photosensitizing Agents MeSH
- pheophorbide a MeSH Browser
- Porphyrins MeSH
- purpurin 18 MeSH Browser
- Spermine MeSH
Photodynamic therapy (PDT) is one of the most promising methods of specific cancer treatment. However, commercially available photosensitizers (PSs) show significant drawbacks, such as side toxicity, low penetration ability, low blood solubility, low tumor selectivity etc. In addition, as was shown previously, a conjugation of polyamines with several toxic agents led to an increased toxicity to cancer cells. Here, we synthesized conjugates of two chlorine photosensitizers, purpurin 18 and pheophorbide a, with spermine in natural and Boc-protected form. Using specialized software, we calculated octanol-water partition coefficients for single protonation state (logP) of single PSs and PS/spermine conjugates. We found that the addition of spermine to chlorine PSs shifted the logP towards higher hydrophilicity in comparison to logP of single chlorines. In vitro studies on several cancer cells indicated that conjugation of purpurin 18 with spermine increased its retention in cancer cells. Using various concentrations of this conjugate, we found that lower concentrations (under 0.2μM) of purpurin 18/spermine conjugate launched apoptosis in HeLa cells. This combined with its high phototoxicity makes the purpurin 18/spermine conjugate a promising photosensitizer for PDT. Obtained results might serve as a basis for further studies of this potential third-generation PS on mammalian models in vivo.
References provided by Crossref.org
PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer